[{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Chairperson","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Guillaume Canaud<\/i><\/u><\/presenter>. Université de Paris, Hôpital Necker-Enfants Malades, Paris, France","CSlideId":"","ControlKey":"a99909b1-0914-4fc3-becd-ec4eadb8a713","ControlNumber":"1167","DisclosureBlock":"&nbsp;<b>&nbsp;G. Canaud:<\/b>  ; Consulting fees; Novartis. ; Novartis. ; Fresenius Medical Care. ; Consulting fees; Fresenius Medical Care. ; Consulting fees; BridgeBio. ; BridgeBio. ; Consulting fees; Alkermes. ; Consulting fees; Vaderis. ; Vaderis.","End":"4\/13\/2022 10:16:00 AM","HasWebcast":null,"Highlights":[],"Id":"254","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"1","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Guillaume Canaud","PresenterKey":"ead0c6f7-c956-49ba-ab16-0bb2492542c9","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Chairperson","SearchResultFooter":"","SearchResultHeader":"Apr 13 2022 10:15AM","SessionId":"96","SessionOnDemand":"False","SessionTitle":"Cancer Drugs Repurposing for Rare Genetic Disorders: A Unique Opportunity for Patients","ShowChatLink":"false","Start":"4\/13\/2022 10:15:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Chairperson","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Guillaume Canaud<\/i><\/u><\/presenter>. Université de Paris, Hôpital Necker-Enfants Malades, Paris, France","CSlideId":"","ControlKey":"19382372-17f4-4e20-906d-71151c00ade4","ControlNumber":"9453","DisclosureBlock":"","End":"4\/13\/2022 10:20:00 AM","HasWebcast":null,"Highlights":[],"Id":"20898","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"2","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Guillaume Canaud","PresenterKey":"ead0c6f7-c956-49ba-ab16-0bb2492542c9","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Introduction","SearchResultFooter":"","SearchResultHeader":"Apr 13 2022 10:15AM","SessionId":"96","SessionOnDemand":"False","SessionTitle":"Cancer Drugs Repurposing for Rare Genetic Disorders: A Unique Opportunity for Patients","ShowChatLink":"false","Start":"4\/13\/2022 10:15:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Introduction","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Guillaume Canaud<\/i><\/u><\/presenter>. Université de Paris, Hôpital Necker-Enfants Malades, Paris, France","CSlideId":"","ControlKey":"95ca12a7-3486-4db0-8d63-df99ca290a74","ControlNumber":"2589","DisclosureBlock":"","End":"4\/13\/2022 10:40:00 AM","HasWebcast":null,"Highlights":[],"Id":"320","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"3","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Guillaume Canaud","PresenterKey":"ead0c6f7-c956-49ba-ab16-0bb2492542c9","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"PIK3CA-related disorders: A breakthrough in drug repurposing","SearchResultFooter":"","SearchResultHeader":"Apr 13 2022 10:15AM","SessionId":"96","SessionOnDemand":"False","SessionTitle":"Cancer Drugs Repurposing for Rare Genetic Disorders: A Unique Opportunity for Patients","ShowChatLink":"false","Start":"4\/13\/2022 10:20:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"PIK3CA-related disorders: A breakthrough in drug repurposing","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"80f950f5-e355-43fe-9e3a-522f0a8de206","ControlNumber":"9109","DisclosureBlock":"","End":"4\/13\/2022 10:45:00 AM","HasWebcast":null,"Highlights":[],"Id":"20503","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"4","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr 13 2022 10:15AM","SessionId":"96","SessionOnDemand":"False","SessionTitle":"Cancer Drugs Repurposing for Rare Genetic Disorders: A Unique Opportunity for Patients","ShowChatLink":"false","Start":"4\/13\/2022 10:40:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Carl Allen<\/i><\/u><\/presenter>. Baylor College of Medicine, Houston, TX","CSlideId":"","ControlKey":"9003c967-534c-4fb5-a979-858c0717cdc8","ControlNumber":"7538","DisclosureBlock":"<b>&nbsp;C. Allen, <\/b> <br><b>Sobi<\/b> Grant\/Contract, No. <br><b>Atara<\/b> Grant\/Contract, No.","End":"4\/13\/2022 11:05:00 AM","HasWebcast":null,"Highlights":[],"Id":"12318","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"5","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Carl Allen, MD, PhD","PresenterKey":"c38810ae-22b5-4df8-b175-5a8e12fb3169","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Langerhans cell histiocytosis at the era of targeted therapies","SearchResultFooter":"","SearchResultHeader":"Apr 13 2022 10:15AM","SessionId":"96","SessionOnDemand":"False","SessionTitle":"Cancer Drugs Repurposing for Rare Genetic Disorders: A Unique Opportunity for Patients","ShowChatLink":"false","Start":"4\/13\/2022 10:45:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Langerhans cell histiocytosis at the era of targeted therapies","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"12a10259-8f83-4f65-ade9-0f6178c98cc3","ControlNumber":"9110","DisclosureBlock":"","End":"4\/13\/2022 11:10:00 AM","HasWebcast":null,"Highlights":[],"Id":"20504","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"6","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr 13 2022 10:15AM","SessionId":"96","SessionOnDemand":"False","SessionTitle":"Cancer Drugs Repurposing for Rare Genetic Disorders: A Unique Opportunity for Patients","ShowChatLink":"false","Start":"4\/13\/2022 11:05:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Satyamaanasa Polubothu<\/i><\/u><\/presenter>. University College London, London, United Kingdom","CSlideId":"","ControlKey":"cac935a0-548d-43f2-95b3-ae3a623b565d","ControlNumber":"9011","DisclosureBlock":"&nbsp;<b>S. Polubothu, <\/b> None.","End":"4\/13\/2022 11:30:00 AM","HasWebcast":null,"Highlights":[],"Id":"19398","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"7","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Satyamaanasa Polubothu, MD, PhD","PresenterKey":"dd363f58-7d8d-4abb-8407-9efff71a3f8f","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Unravelling sporadic vascular malformations due to mosaic RAS\/MAPK variants: New therapeutic perspectives","SearchResultFooter":"","SearchResultHeader":"Apr 13 2022 10:15AM","SessionId":"96","SessionOnDemand":"False","SessionTitle":"Cancer Drugs Repurposing for Rare Genetic Disorders: A Unique Opportunity for Patients","ShowChatLink":"false","Start":"4\/13\/2022 11:10:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Unravelling sporadic vascular malformations due to mosaic RAS\/MAPK variants: New therapeutic perspectives","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"00af87eb-0fe6-4d02-bf4c-ba34ff5b5c0c","ControlNumber":"2591","DisclosureBlock":"","End":"4\/13\/2022 11:35:00 AM","HasWebcast":null,"Highlights":[],"Id":"321","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"8","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr 13 2022 10:15AM","SessionId":"96","SessionOnDemand":"False","SessionTitle":"Cancer Drugs Repurposing for Rare Genetic Disorders: A Unique Opportunity for Patients","ShowChatLink":"false","Start":"4\/13\/2022 11:30:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"a726729d-74cd-41b2-a12c-e0e1bbbafc98","ControlNumber":"9111","DisclosureBlock":"","End":"4\/13\/2022 11:45:00 AM","HasWebcast":null,"Highlights":[],"Id":"20505","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"9","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"General Discussion","SearchResultFooter":"","SearchResultHeader":"Apr 13 2022 10:15AM","SessionId":"96","SessionOnDemand":"False","SessionTitle":"Cancer Drugs Repurposing for Rare Genetic Disorders: A Unique Opportunity for Patients","ShowChatLink":"false","Start":"4\/13\/2022 11:35:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"General Discussion","Topics":null,"cSlideId":""}]